Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Vericel Corp Director's Dealing 2022

Mar 3, 2022

31799_dirs_2022-03-03_5ec9660b-b2c9-4492-b33e-37695b8dc2b2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vericel Corp (VCEL)
CIK: 0000887359
Period of Report: 2022-03-01

Reporting Person: Hopper Jonathan Mark (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-03-01 Common Stock M 10000 $10.95 Acquired 55914 Direct
2022-03-01 Common Stock S 10000 $41.406 Disposed 45914 Direct
2022-03-01 Common Stock M 10000 $18 Acquired 55914 Direct
2022-03-01 Common Stock S 6738 $41.462 Disposed 49176 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-03-01 Stock Option (right to buy) $10.95 M 10000 Disposed 2028-08-20 Common Stock (10000) Direct
2022-03-01 Stock Option (right to buy) $18 M 10000 Disposed 2030-02-11 Common Stock (10000) Direct

Footnotes

F1: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

F2: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2021.

F3: These options, representing the right to purchase 135,000 shares, became exercisable on August 20, 2019, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company.

F4: These options, representing the right to purchase 48,750 shares, became exercisable in quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 11, 2020.